FDA Webview
X

Free FDA Notices

Panel to Discuss BLA for Anthrax

09/25/2009

Federal Register Notice: FDA’s Anti-Infective Drugs Advisory Committee will meet 10/27, from 8 a.m. to 5 p.m. at the Hilton Washington DC/Silver Spring, The Ballrooms, 8727 Colesville Rd., Silver Spring, MD. Contact Minh Doan, (301) 827- 7001. The committee will discuss a Human Genome Sciences, Inc. BLA for raxibacumab injection for treating inhalational anthrax disease. To view this notice, click here.

LATEST NEWS